##{"id":98475,"date":"2021-12-06T13:14:39","date_gmt":"2021-12-06T02:14:39","guid":{"rendered":"https:\/\/www.fnarena.com\/index.php\/2021\/12\/06\/australian-broker-call-extra-edition-dec-06-2021\/"},"modified":"2021-12-06T13:14:39","modified_gmt":"2021-12-06T02:14:39","slug":"australian-broker-call-extra-edition-dec-06-2021","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2021\/12\/06\/australian-broker-call-extra-edition-dec-06-2021\/","title":{"rendered":"Australian Broker Call *Extra* Edition &#8211; Dec 06, 2021"},"content":{"rendered":"<p><strong>An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed&nbsp;equities.<\/strong><\/p>\n<p>In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena&nbsp;has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed&nbsp;stocks, also enlarging the number of stocks that make up the FNArena&nbsp;universe.<\/p>\n<p>One key difference is the *Extra* Edition will not be updated daily, but merely &quot;regularly&quot; depending on availability&nbsp;of&nbsp;suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.<\/p>\n<p>Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication&nbsp;may not be up to date, or yet awaiting another update by FNArena&#039;s&nbsp;team of journalists.<\/p>\n<p>Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.<\/p>\n<p>The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.<\/p>\n<p>The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.<\/p>\n<p><strong>COMPANIES DISCUSSED IN THIS ISSUE<\/strong><\/p>\n<p>Click on a symbol for fast access.<br \/>The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)<\/p>\n<p><a href=\"#ABB\" style=\"font-weight:bold\">ABB<\/a>&nbsp;&nbsp; <a href=\"#CCP\" style=\"font-weight:bold\">CCP<\/a>&nbsp;&nbsp; <a href=\"#CKF\" style=\"font-weight:bold\">CKF<\/a>&nbsp;&nbsp; <a href=\"#CQR\" style=\"font-weight:bold\">CQR<\/a>&nbsp;&nbsp; <a href=\"#ERD\" style=\"font-weight:bold\">ERD<\/a>&nbsp;&nbsp; <a href=\"#FPH\" style=\"font-weight:bold\">FPH<\/a>&nbsp;&nbsp; <a href=\"#HCW\" style=\"font-weight:bold\">HCW<\/a>&nbsp;&nbsp; <a href=\"#HUB\" style=\"font-weight:bold\">HUB<\/a>&nbsp;&nbsp; <a href=\"#NST\" style=\"font-weight:bold\">NST<\/a>&nbsp;&nbsp; <a href=\"#NWL\" style=\"font-weight:bold\">NWL<\/a>&nbsp;&nbsp; <a href=\"#OBL\" style=\"font-weight:bold\">OBL<\/a>&nbsp;&nbsp; <a href=\"#PPG\" style=\"font-weight:bold\">PPG<\/a>&nbsp;&nbsp; <a href=\"#SMP\" style=\"font-weight:bold\">SMP<\/a>&nbsp;&nbsp; <a href=\"#SND\" style=\"font-weight:bold\">SND<\/a>&nbsp;&nbsp; <a href=\"#TSI\" style=\"font-weight:bold\">TSI<\/a>&nbsp;&nbsp; <a href=\"#YOJ\" style=\"font-weight:bold\">YOJ<\/a>&nbsp;&nbsp; <a href=\"#Z2U\" style=\"font-weight:bold\">Z2U<\/a>&nbsp;&nbsp;<\/p>\n<h2><a name=\"ABB\">ABB<\/a>&nbsp;&nbsp;&nbsp; AUSSIE BROADBAND LIMITED<\/h2>\n<p><strong>Telecommunication &#8211; Overnight Price: $5.02 <\/strong><\/p>\n<p>JP Morgan rates ((ABB)) as Overweight (1) &#8211;<\/p>\n<p>After Aussie Broadband confirmed its commitment to acquire Over The Wire Holdings ((OTW)), JP Morgan assumes the transaction will be -5% dilutive for net present value. The consideration is $5.75 a&nbsp;share with various options for cash or equity.<\/p>\n<p>Not only is the company raising equity below the broker&#039;s valuation, but&nbsp;the acquired assets will have slower earnings growth. Despite the lower valuation,&nbsp;the transaction is estimated to be&nbsp;8% EPS accretive by the second year, not including synergies.<\/p>\n<p>Overweight rating is maintained.&nbsp;Target price slips to $6.20 from $6.50.<\/p>\n<p>This report was published on December 3, 2021.<\/p>\n<p>Target price is <strong>$6.20<\/strong> Current Price is <strong>$5.02 <\/strong> Difference: <strong>$1.18<\/strong><br \/>If <strong>ABB<\/strong> meets the JP Morgan target it will return approximately <strong> 24%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>80.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>6.27<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>21.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.90<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CCP\">CCP<\/a>&nbsp;&nbsp;&nbsp; CREDIT CORP GROUP LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $31.63 <\/strong><\/p>\n<p>Canaccord Genuity rates ((CCP)) as Hold (3) &#8211;<\/p>\n<p>Credit Corp&nbsp;has struck a debt-funded deal to buy Thorn Group&#039;s ((TGA)) Radio Rentals for $60m and management upgrades profit guidance.<\/p>\n<p>Cannacord Genuity&nbsp;says the deal will improve domestic debt purchase volumes at a time when credit card balances and arrears are declining.&nbsp;<\/p>\n<p>The broker says the company still has $300m in the kitty for further deals, which it considers to be&nbsp;the main upside catalyst.&nbsp;EPS forecasts rise 1.2% in FY22; and 2.7% in FY23.<\/p>\n<p>Hold rating retained,&nbsp;target price rises to $33.25 from&nbsp;$28.80.&nbsp;<\/p>\n<p>This report was published on December 1, 2021.<\/p>\n<p>Target price is <strong>$33.25<\/strong> Current Price is <strong>$31.63 <\/strong> Difference: <strong>$1.62<\/strong><br \/>If <strong>CCP<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 5%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$35.60<\/strong>, suggesting upside of <strong>14.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>77.00<\/strong> cents and EPS of <strong>144.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.43%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.97<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>142.3<\/strong>, implying annual growth of <strong>8.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>75.7<\/strong>, implying a prospective dividend yield of <strong>2.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>21.8<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>90.00<\/strong> cents and EPS of <strong>168.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.85%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.83<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>161.6<\/strong>, implying annual growth of <strong>13.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>83.3<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>19.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CKF\">CKF<\/a>&nbsp;&nbsp;&nbsp; COLLINS FOODS LIMITED<\/h2>\n<p><strong>Food, Beverages &amp; Tobacco &#8211; Overnight Price: $13.18 <\/strong><\/p>\n<p>Canaccord Genuity rates ((CKF)) as Buy (1) &#8211;<\/p>\n<p>Collins Foods&#039; first-half result outpaced&nbsp;Cannacord Genuity&#039;s forecasts, posting a good margin performance in Europe, reasonable comps for KFC Australia, and progress on store rollouts globally.<\/p>\n<p>EPS forecasts rise 3% in FY22 and 1% in FY23.<\/p>\n<p>Target price rises to $14.85 from $14.10.&nbsp;Buy rating retained.<\/p>\n<p>The report was published on December 1, 2021.<\/p>\n<p>Target price is <strong>$14.85<\/strong> Current Price is <strong>$13.18 <\/strong> Difference: <strong>$1.67<\/strong><br \/>If <strong>CKF<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 13%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$14.53<\/strong>, suggesting upside of <strong>13.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in May.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>28.00<\/strong> cents and EPS of <strong>52.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.12%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>25.35<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>49.9<\/strong>, implying annual growth of <strong>76.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>27.5<\/strong>, implying a prospective dividend yield of <strong>2.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>25.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>31.00<\/strong> cents and EPS of <strong>56.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.54<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>54.6<\/strong>, implying annual growth of <strong>9.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>30.2<\/strong>, implying a prospective dividend yield of <strong>2.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>23.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CQR\">CQR<\/a>&nbsp;&nbsp;&nbsp; CHARTER HALL RETAIL REIT<\/h2>\n<p><strong>REITs &#8211; Overnight Price: $4.11 <\/strong><\/p>\n<p>JP Morgan rates ((CQR)) as Neutral (3) &#8211;<\/p>\n<p>Charter Hall Retail REIT has lifted EPS guidance to no less than 28.2cpu&nbsp;from prior guidance of 27.8-28.2cpu, and DPS of no less than 24.3cps from 23.9-24.3cps.&nbsp;<\/p>\n<p>JP Morgan adjusts its forecasts not only&nbsp;for the revised guidance but also for the -$50m acquisition of a&nbsp;49% stake in an Ampol&nbsp;((ALD))<br \/>Fuel &amp; Convenience Retail Centre portfolio.<\/p>\n<p>Neutral rating and $4 target price are retained.<\/p>\n<p>This report was published on December 2, 2021.<\/p>\n<p>Target price is <strong>$4.00<\/strong> Current Price is <strong>$4.11 <\/strong> Difference: <strong>minus $0.11<\/strong> (current price is over target).<br \/>If <strong>CQR<\/strong> meets the JP Morgan target it will return approximately <strong>minus 3%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$4.18<\/strong>, suggesting upside of <strong>1.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY22<\/strong> dividend of <strong>24.00<\/strong> cents and EPS of <strong>28.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.84%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.68<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>28.1<\/strong>, implying annual growth of <strong>-44.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>24.7<\/strong>, implying a prospective dividend yield of <strong>6.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY23<\/strong> dividend of <strong>27.00<\/strong> cents and EPS of <strong>30.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.57%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.70<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>29.1<\/strong>, implying annual growth of <strong>3.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>26.3<\/strong>, implying a prospective dividend yield of <strong>6.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"ERD\">ERD<\/a>&nbsp;&nbsp;&nbsp; EROAD LIMITED<\/h2>\n<p><strong>Transportation &amp; Logistics &#8211; Overnight Price: $4.68 <\/strong><\/p>\n<p>Bell Potter rates ((ERD)) as Buy (1) &#8211;<\/p>\n<p>EROAD&#039;s&nbsp;first-half underlying earnings (EBITDA) slightly missed&nbsp;Bell Potter&#039;s estimate, due mainly to higher Corporate expenses.&nbsp;The broker reduces its underlying EPS estimates and lowers its target price to $5.95 from $6.05.<\/p>\n<p>Buy rating retained.&nbsp;<\/p>\n<p>The analyst points out it&#039;s only&nbsp;early stages in expanding the platform offering and enterprise sales initiatives in North America and Australia. The recent&nbsp;Coretex&nbsp;acquisition is expected to accelerate this process in 2022.<\/p>\n<p>This report was published on November 30, 2021.<\/p>\n<p>Target price is <strong>$5.95<\/strong> Current Price is <strong>$4.68 <\/strong> Difference: <strong>$1.27<\/strong><br \/>If <strong>ERD<\/strong> meets the Bell Potter target it will return approximately <strong> 27%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in March.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.85<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 552.54<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>4.05<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>115.67<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>NZD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"FPH\">FPH<\/a>&nbsp;&nbsp;&nbsp; FISHER &amp; PAYKEL HEALTHCARE CORPORATION LIMITED<\/h2>\n<p><strong>Medical Equipment &amp; Devices &#8211; Overnight Price: $30.81 <\/strong><\/p>\n<p>Wilsons rates ((FPH)) as Overweight (1) &#8211;<\/p>\n<p>Wilsons&nbsp;concedes that&nbsp;it is hard to maintain confidence in Fisher &amp; Paykel Healthcare Corporation&#039;s short-term outlook but says the&nbsp;long growth runway for high-flow nasal cannula technology outside of ICU settings should benefit the company beyond covid&nbsp;impacts.&nbsp;<\/p>\n<p>The company reported a 45% beat to Wilsons&#039; forecast in hospital hardware sales in the first half, driving a 14% beat in profit after tax.&nbsp;<\/p>\n<p>Overweight rating retained.&nbsp;Target price rises to $35.50 from $35.00.<\/p>\n<p>This report was published on November 26, 2021.<\/p>\n<p>Target price is <strong>$35.50<\/strong> Current Price is <strong>$30.81 <\/strong> Difference: <strong>$4.69<\/strong><br \/>If <strong>FPH<\/strong> meets the Wilsons target it will return approximately <strong> 15%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$34.00<\/strong>, suggesting upside of <strong>10.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in March.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>37.64<\/strong> cents and EPS of <strong>65.49<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.22%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>47.04<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>67.7<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>38.4<\/strong>, implying a prospective dividend yield of <strong>1.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>45.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>38.58<\/strong> cents and EPS of <strong>67.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.25%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>45.99<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>65.2<\/strong>, implying annual growth of <strong>-3.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>42.0<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>47.3<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>NZD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"HCW\">HCW<\/a>&nbsp;&nbsp;&nbsp; HEALTHCO HEALTHCARE &amp; WELLNESS REIT<\/h2>\n<p><strong>Overnight Price: $2.22 <\/strong><\/p>\n<p>Goldman Sachs rates ((HCW)) as Initiation of coverage with Buy (1) &#8211;<\/p>\n<p>Goldman Sachs has initiated coverage on HealthCo Healthcare &amp; Wellness REIT with a Buy rating and has added the company to its Conviction List.<\/p>\n<p>HealthCo holds a portfolio of Australian healthcare and wellness assets, mainly in the eastern states.<\/p>\n<p>The broker&#039;s $2.56 target price implies a 22% total return and Goldman Sachs admires the company&#039;s balance sheet, external growth opportunities in the&nbsp;growing Australian market, and relatively secure income stream.<\/p>\n<p>The broker believes the company offers an enticing mix of defence&nbsp;and offence&nbsp;and is underpinned by key mega&nbsp;trends: an ageing population, technological advancement; increased government expenditure and increasing consumption of health-related services.&nbsp;<\/p>\n<p>Target price is <strong>$2.56<\/strong> Current Price is <strong>$2.22 <\/strong> Difference: <strong>$0.34<\/strong><br \/>If <strong>HCW<\/strong> meets the Goldman Sachs target it will return approximately <strong> 15%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>7.00<\/strong> cents and EPS of <strong>5.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.15%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>44.40<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>8.00<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.60%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>24.67<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"HUB\">HUB<\/a>&nbsp;&nbsp;&nbsp; HUB24 LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $27.59 <\/strong><\/p>\n<p>JP Morgan rates ((HUB)) as Underweight (5) &#8211;<\/p>\n<p>JP Morgan had previously allowed in its forecasts&nbsp;for&nbsp;HUB24&#039;s termination of its cash deposit agreements with ANZ&nbsp;Bank ((ANZ)) from December 1, 2022.<\/p>\n<p>Separately,&nbsp;takeover target Class Ltd ((CL1)) should help diversify the company&#039;s&nbsp;business model but will require more investment, cautions the broker.<\/p>\n<p>The analyst notes 1QFY22&nbsp;custody funds under administration (FUA) grew to $45bn, up 9% quarter-on-quarter but believes such strong numbers will be needed&nbsp;to justify the&nbsp;valuation in the face of margin compression.&nbsp;<\/p>\n<p>Underweight rating and $26 target price are retained.<\/p>\n<p>This report was published on December 1, 2021.<\/p>\n<p>Target price is <strong>$26.00<\/strong> Current Price is <strong>$27.59 <\/strong> Difference: <strong>minus $1.59<\/strong> (current price is over target).<br \/>If <strong>HUB<\/strong> meets the JP Morgan target it will return approximately <strong>minus 6%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$34.01<\/strong>, suggesting upside of <strong>27.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY22<\/strong> dividend of <strong>19.10<\/strong> cents and EPS of <strong>52.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.69%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>53.06<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>42.7<\/strong>, implying annual growth of <strong>235.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>16.8<\/strong>, implying a prospective dividend yield of <strong>0.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>62.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY23<\/strong> dividend of <strong>26.20<\/strong> cents and EPS of <strong>67.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.95%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>41.18<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>57.8<\/strong>, implying annual growth of <strong>35.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>23.5<\/strong>, implying a prospective dividend yield of <strong>0.9%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>46.1<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NST\">NST<\/a>&nbsp;&nbsp;&nbsp; NORTHERN STAR RESOURCES LIMITED<\/h2>\n<p><strong>Gold &amp; Silver &#8211; Overnight Price: $8.81 <\/strong><\/p>\n<p>JP Morgan rates ((NST)) as Overweight (1) &#8211;<\/p>\n<p>Northern Star Resources has&nbsp;provided funding (convertible bond) to Osisko Mining in Canada&nbsp;and has secured an exclusive right to negotiate a 50\/50 joint venture&nbsp;on the Windfall development project. If the bond is converted, 9.9% of Windfall&nbsp;would be acquired.<\/p>\n<p>JP Morgan feels the opportunity to set up the Windfall project&nbsp;from the outset likely presents positive upside, compared with the frustrations&nbsp;of introducing Australian mining methods for the Pogo gold mine in Alaska.<\/p>\n<p>Overweight rating and $11 target price retained.<\/p>\n<p>This report was published on December 2, 2021.<\/p>\n<p>Target price is <strong>$11.00<\/strong> Current Price is <strong>$8.81 <\/strong> Difference: <strong>$2.19<\/strong><br \/>If <strong>NST<\/strong> meets the JP Morgan target it will return approximately <strong> 25%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$11.86<\/strong>, suggesting upside of <strong>30.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY22<\/strong> dividend of <strong>26.00<\/strong> cents and EPS of <strong>39.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.95%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>22.59<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>30.4<\/strong>, implying annual growth of <strong>-73.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>24.2<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>29.9<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY23<\/strong> dividend of <strong>31.00<\/strong> cents and EPS of <strong>50.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.52%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.62<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>32.2<\/strong>, implying annual growth of <strong>5.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.7<\/strong>, implying a prospective dividend yield of <strong>2.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>28.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NWL\">NWL<\/a>&nbsp;&nbsp;&nbsp; NETWEALTH GROUP LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $15.19 <\/strong><\/p>\n<p>JP Morgan rates ((NWL)) as Neutral (3) &#8211;<\/p>\n<p>JP Morgan notes 1QFY22&nbsp;custody funds under administration (FUA) grew to $52bn, up 10% quarter-on-quarter but says such strong numbers will be needed&nbsp;to justify the valuation given margin compression.&nbsp;<\/p>\n<p>After the RBA has opened the door for a rate rise prior to 2024, the analyst believes the group will&nbsp;take advantage of initial rate rises (up to 50 basis points) before passing it on to its users.<\/p>\n<p>Neutral rating and $14.50 target price are retained.<\/p>\n<p>This report was published on December 1, 2021.<\/p>\n<p>Target price is <strong>$14.50<\/strong> Current Price is <strong>$15.19 <\/strong> Difference: <strong>minus $0.69<\/strong> (current price is over target).<br \/>If <strong>NWL<\/strong> meets the JP Morgan target it will return approximately <strong>minus 5%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$17.97<\/strong>, suggesting upside of <strong>19.9%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY22<\/strong> dividend of <strong>21.00<\/strong> cents and EPS of <strong>27.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.38%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>56.26<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>26.5<\/strong>, implying annual growth of <strong>17.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>21.1<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>56.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>JP Morgan forecasts a full year <strong>FY23<\/strong> dividend of <strong>24.00<\/strong> cents and EPS of <strong>30.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.58%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>50.63<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>31.7<\/strong>, implying annual growth of <strong>19.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.5<\/strong>, implying a prospective dividend yield of <strong>1.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>47.3<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.6<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"OBL\">OBL<\/a>&nbsp;&nbsp;&nbsp; OMNI BRIDGEWAY LIMITED<\/h2>\n<p><strong>Diversified Financials &#8211; Overnight Price: $3.23 <\/strong><\/p>\n<p>Goldman Sachs rates ((OBL)) as Buy (1) &#8211;<\/p>\n<p>Omni Bridgeway&#039;s AGM update reveals a good year-to-date performance and good earnings potential from its investments.<\/p>\n<p>Fund 1 is outpacing Goldman Sachs&#039; estimates and the broker expects it will generate cash sooner than forecast.<\/p>\n<p>The broker says that if the company&#039;s investments were sold today, they would bring between $470m and $1bn, compared with a market capitalisation, less cash and receivables, of $663m.<\/p>\n<p>Omni Bridgeway boasts a comfortable capital position, some of which could be returned to shareholders or fund growth, says the broker.<\/p>\n<p>Buy rating is retained. Target price inches up&nbsp;to $5.35 from $5.30.<\/p>\n<p>This report was published on November 30, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$5.35<\/strong> Current Price is <strong>$3.23 <\/strong> Difference: <strong>$2.12<\/strong><br \/>If <strong>OBL<\/strong> meets the Goldman Sachs target it will return approximately <strong> 66%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>4.00<\/strong> cents and EPS of <strong>15.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.24%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.53<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>33.00<\/strong> cents and EPS of <strong>131.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>10.22%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>2.47<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PPG\">PPG<\/a>&nbsp;&nbsp;&nbsp; PRO-PAC PACKAGING LIMITED<\/h2>\n<p><strong>Overnight Price: $0.19 <\/strong><\/p>\n<p>Shaw and Partners rates ((PPG)) as Downgrade to Hold from Buy (3) &#8211;<\/p>\n<p>After allowing for a 10:1 share consolidation, Shaw and Partners&nbsp;lowers its&nbsp;target price to $2.32 from $3.00 after a trading update by Pro-Pac Packaging. The broker also lowers its rating to Hold from Buy and awaits further evidence of more normal trading conditions.<\/p>\n<p>Cost pressures and operational effects overshadowed revenue growth in the core Flexibles business, and first-half&nbsp;profit&nbsp;guidance missed the&nbsp;broker&#039;s estimate.<\/p>\n<p>The analyst is waiting to assess the impact of&nbsp;company-instituted price&nbsp;increases upon the customer base, as well as the future direction of freight, resin and labour costs.<\/p>\n<p>This report was published on November 30, 2021.<\/p>\n<p>Target price is <strong>$2.32<\/strong> Current Price is <strong>$0.19 <\/strong> Difference: <strong>$2.13<\/strong><br \/>If <strong>PPG<\/strong> meets the Shaw and Partners target it will return approximately <strong> 1121%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>3.40<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>17.89%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>2.11<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>7.00<\/strong> cents and EPS of <strong>17.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>36.84%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>1.08<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SMP\">SMP<\/a>&nbsp;&nbsp;&nbsp; SMARTPAY HOLDINGS LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $0.75 <\/strong><\/p>\n<p>Shaw and Partners rates ((SMP)) as Buy (1) &#8211;<\/p>\n<p>After reviewing&nbsp;first-half results for&nbsp;Smartpay, and&nbsp;assessing that October trading suggests a strong outlook,&nbsp;Shaw and Partners lifts its target price to $1.20 from $1.15. Buy rating retained.<\/p>\n<p>The analyst estimates the Australian business alone is worth more than the company&rsquo;s entire valuation (the New Zealand business is estimated to be worth $0.30\/share).<\/p>\n<p>When taking into account covid lockdowns, the broker says operating leverage is emerging.&nbsp;Gross margins&nbsp;came in at 64.6%, 1.5% ahead of Shaw and Partners estimate of 63.1%.<\/p>\n<p>This report was published on November 30, 2021.<\/p>\n<p>Target price is <strong>$1.20<\/strong> Current Price is <strong>$0.75 <\/strong> Difference: <strong>$0.45<\/strong><br \/>If <strong>SMP<\/strong> meets the Shaw and Partners target it will return approximately <strong> 60%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in March.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>1.60<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>46.88<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>3.48<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.54<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>NZD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SND\">SND<\/a>&nbsp;&nbsp;&nbsp; SAUNDERS INTERNATIONAL LIMITED<\/h2>\n<p><strong>Industrial Sector Contractors &amp; Engineers &#8211; Overnight Price: $0.93 <\/strong><\/p>\n<p>CCZ Equities rates ((SND)) as Buy (1) &#8211;<\/p>\n<p>Saunders International has secured its largest contract to date, a $165m deal with Crowley Solutions for the design and construction management of a US Defence fuel-storage facility. CCZ Equities says the risk of inflated costs is low given pricing is largely locked in.&nbsp;<\/p>\n<p>CCZ expects 25% of project revenue in FY22, 60% in FY23 and 15% in FY24,&nbsp;and the broker&nbsp;raises&nbsp;EPS&nbsp;forecasts 10.5%, 27.3% and 14.9% respectively.&nbsp;<\/p>\n<p>Target price rises to $1.10 from $0.95. Buy retained.<\/p>\n<p>This report was published on November 22, 2021.<\/p>\n<p>Target price is <strong>$1.10<\/strong> Current Price is <strong>$0.93 <\/strong> Difference: <strong>$0.17<\/strong><br \/>If <strong>SND<\/strong> meets the CCZ Equities target it will return approximately <strong> 18%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY22<\/strong> dividend of <strong>1.80<\/strong> cents and EPS of <strong>3.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.94%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.85<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY23<\/strong> dividend of <strong>3.30<\/strong> cents and EPS of <strong>7.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.55%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>12.74<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TSI\">TSI<\/a>&nbsp;&nbsp;&nbsp; TOP SHELF INTERNATIONAL HOLDINGS LIMITED<\/h2>\n<p><strong>Food, Beverages &amp; Tobacco &#8211; Overnight Price: $1.57 <\/strong><\/p>\n<p>Canaccord Genuity rates ((TSI)) as Initiation of coverage with Buy (1) &#8211;<\/p>\n<p>Cannacord Genuity initiates coverage on Top Shelf International Holdings with a Buy rating and $2.51 target price.<\/p>\n<p>The broker says the company is strategically well positioned in the &quot;scale craft&quot; category and cites a large attainable market, open to disruption by local and differentiated brands.<\/p>\n<p>The broker notes the&nbsp;company has a proven track record of execution, more than doubled sales in&nbsp;FY21 to $20m,&nbsp;and boasts several growth levers, including: premiumisation; maturation; provenance;&nbsp;and a recently launched vodka brand.<\/p>\n<p>The company&nbsp;is well positioned in the agave spirit market, which is experiencing supply constraints given the long plant maturation period.<\/p>\n<p>Target price is <strong>$2.51<\/strong> Current Price is <strong>$1.57 <\/strong> Difference: <strong>$0.94<\/strong><br \/>If <strong>TSI<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 60%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 17.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 9.24<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 8.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 19.63<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"YOJ\">YOJ<\/a>&nbsp;&nbsp;&nbsp; YOJEE LIMITED<\/h2>\n<p><strong>Software &amp; Services &#8211; Overnight Price: $0.17 <\/strong><\/p>\n<p>CCZ Equities rates ((YOJ)) as No Rating (-1) &#8211;<\/p>\n<p>CCZ Equities initiates coverage on Singapore-based logistics company Yojee. The broker notes Yogee is targeting a rollout of 126 revenue-generating hubs in 19 Australia-Pacific countries&nbsp;in the next three years to support expansion requests from three clients.&nbsp;<\/p>\n<p>As clients continue to expand contracts, CCZ says Yojee&nbsp;is positioned to capitalise&nbsp;on a $43.5m addressable revenue base by FY25, implying a 158% four-year revenue compound annual growth rate. Expansion in other regions offers upside risk.<\/p>\n<p>Target price is&nbsp;45c. No rating provided.<\/p>\n<p>This report was published on November 25, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$0.45<\/strong> Current Price is <strong>$0.17 <\/strong> Difference: <strong>$0.28<\/strong><br \/>If <strong>YOJ<\/strong> meets the CCZ Equities target it will return approximately <strong> 165%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.70<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 24.29<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>CCZ Equities forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 42.50<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"Z2U\">Z2U<\/a>&nbsp;&nbsp;&nbsp; ZOOM2U TECHNOLOGIES LIMITED<\/h2>\n<p><strong>Overnight Price: $0.39 <\/strong><\/p>\n<p>Shaw and Partners rates ((Z2U)) as Buy (1) &#8211;<\/p>\n<p>Shaw and Partners&nbsp;considers Zoom2U Technologies&#039; AGM trading update points to encouraging second-quarter&nbsp;progress.<\/p>\n<p>Buy rating and $0.65 target price are retained, the&nbsp;broker having recently initiated coverage.<\/p>\n<p>The Zoom2U platform recently signed Best &amp; Less as a customer and is working on trial opportunities with large customers. Meanwhile, the Locate2u platform has signed Bing Lee as a second enterprise customer and now has more than 100 subscribers.<\/p>\n<p>This report was published on November 30 , 2021.<\/p>\n<p>Target price is <strong>$0.65<\/strong> Current Price is <strong>$0.39 <\/strong> Difference: <strong>$0.26<\/strong><br \/>If <strong>Z2U<\/strong> meets the Shaw and Partners target it will return approximately <strong> 67%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 2.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 16.25<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 2.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 19.50<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p><strong>Disclaimer:<\/strong><br \/>The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don&#039;t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.<\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Extra Edition of the Broker Call Report<\/p>\n","protected":false},"author":3,"featured_media":98476,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[84],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/98475"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=98475"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/98475\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media\/98476"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=98475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=98475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=98475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}